Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.28 EUR
Change Today -0.002 / -0.70%
Volume 0.0
LYF On Other Exchanges
As of 2:08 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Avon House

19 Stanwell Road


Cardiff, CF64 2EZ

United Kingdom

Phone: 44 29 2071 0570

Fax: 44 29 2070 5715

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East and Africa, and internationally. It offers glycated hemoglobin (HbA1c) analyzers, such as Quo-Test, Quo-Lab, and Biosen HbA1c analyzers for monitoring diabetes. The company also provides hemoglobin analyzers, including Hemo Control, a hemoglobin analyzer that provides quantitative lab quality results within 25 seconds for blood banks, hospitals, and clinics; Hemo Vet for veterinary use; STAT-Site, a hand-held hemoglobin analyzer; UltraCrit, a hematocrit measurement device for blood donor screening; HemataSTAT, a microhematocrit system, which offers quantitative hematocrit; and DiaSpect Hemoglobin T and DiaSpect Tm, the hemoglobin measurement systems. In addition, it offers glucose analyzers, such as C-Line GP+, C-Line Clinic, and S-Line Lab+ used in laboratories and sports institutions; and lactate analyzers comprising Biosen C-Line and S-Line glucose and lactate analyzers, as well as Lactate Scout+, a blood lactate analyzer for athletes, coaches, amateurs, and sport scientists. Further, the company provides rapid testing services, including pregnancy tests, such as True20 and QuPID for urine only or urine and serum pregnancy testing; and infectious diseases tests, such as H. Pylori, RELY Mono, RELY, and Strep A for the detection of pathonogenic micro-organisms, such as bacteria, parasites, viruses, and fungi. Additionally, it offers Sepsis testing services; clinical chemistry reagents; and diagnostic biomarker-based enzyme-linked immunosorbent assay kits and rapid tests, as well as maternal and women health diagnostic solutions. The company sells its products to GP surgeries, pharmacies, blood banks, sports clinics, hospitals, and laboratories through a network of distributors. EKF Diagnostics Holdings plc was founded in 1990 and is headquartered in Cardiff, the United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LYF:GR €0.28 EUR -0.002

LYF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LYF.
View Industry Companies

Industry Analysis


Industry Average

Valuation LYF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EKF DIAGNOSTICS HOLDINGS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at